Jan Albert

22.5k total citations · 1 hit paper
274 papers, 13.0k citations indexed

About

Jan Albert is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jan Albert has authored 274 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 198 papers in Virology, 177 papers in Infectious Diseases and 65 papers in Epidemiology. Recurrent topics in Jan Albert's work include HIV Research and Treatment (198 papers), HIV/AIDS drug development and treatment (120 papers) and HIV/AIDS Research and Interventions (112 papers). Jan Albert is often cited by papers focused on HIV Research and Treatment (198 papers), HIV/AIDS drug development and treatment (120 papers) and HIV/AIDS Research and Interventions (112 papers). Jan Albert collaborates with scholars based in Sweden, United States and United Kingdom. Jan Albert's co-authors include Thomas Leitner, Birgitta Åsjö, Éva Mária Fenyõ, E M Fenyö, Gunnel Biberfeld, Linda Morfeldt-Månson, Mathias Uhlén, Francesca Chiodi, Knut Lidman and Annette Alaeus and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jan Albert

270 papers receiving 12.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations

1989 566 citations Jan Albert, Linda Morfeldt-Månson et al. profile →

Peers

Countries citing papers authored by Jan Albert

Since Specialization

Citations

This map shows the geographic impact of Jan Albert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Albert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Albert more than expected).

Fields of papers citing papers by Jan Albert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Albert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Albert. The network helps show where Jan Albert may publish in the future.

Co-authorship network of co-authors of Jan Albert

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Albert. A scholar is included among the top collaborators of Jan Albert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Albert. Jan Albert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sweden surpasses the UNAIDS 95-95-95 target: estimating HIV-1 incidence, 2003 to 2022 2024 ·Eurosurveillance ·Erik Lundgren, (unknown), Ethan Romero-Severson, Mirjana Dimitrijević, (unknown), (unknown), Christina Carlander, (unknown), Hans Norrgren, Fredrik Månsson, Olof Elvstam, Magnus Gisslén, (unknown), Anders Sönnerborg, Jan Albert, Thomas Leitner	4
2	Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates 2022 ·Clinical & Translational Immunology ·Xaquín Castro Dopico, Sandra Muschiol, Nastasiya F. Grinberg, Soo Aleman, Daniel J. Sheward, Leo Hanke, (unknown), (unknown), Mattias N.E. Forsell, Jonathan M. Coquet, Gerald M. McInerney, Joakim Dillner, Gordana Bogdanović, Ben Murrell, Jan Albert, Chris Wallace, Gunilla B. Karlsson Hedestam	3
3	Getting more from heterogeneous HIV-1 surveillance data in a high immigration country: estimation of incidence and undiagnosed population size using multiple biomarkers 2019 ·International Journal of Epidemiology ·Federica Giardina, Ethan Romero-Severson, Maria Axelsson, Veronica Svedhem, Thomas Leitner, Tom Britton, Jan Albert	13
4	In vivo mutation rates and the landscape of fitness costs of HIV-1 2017 ·Virus Evolution ·Fabio Zanini, Vadim Puller, Johanna Brodin, Jan Albert, Richard A. Neher	56
5	Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression 2008 ·Retrovirology ·(unknown), Johanna Repits, (unknown), Jasminka Sterjovski, Melissa J. Churchill, Damian F. J. Purcell, Anders Karlsson, Jan Albert, Paul R. Gorry, Marianne Jansson	21
6	Short Communication: HIV Type 2 Dynamics 2005 ·AIDS Research and Human Retroviruses ·(unknown), Christina Broström, (unknown), Sebastian Bonhoeffer, Jan Albert	2
7	Cerebrospinal Fluid Viral Load, Virus Isolation, and Intrathecal Immunoactivation in HIV Type 2 Infection 2004 ·AIDS Research and Human Retroviruses ·(unknown), Magnus Gisslén, Jan Albert, (unknown), Bo Svennerholm, Dietmar Fuchs, Lars Hagberg	5
8	Identification of Two CRF11-cpx Genomes and Two Preliminary Representatives of a New Circulating Recombinant Form (CRF13-cpx) of HIV Type 1 in Cameroon 2002 ·AIDS Research and Human Retroviruses ·Karin Wilbe Ramsay, Charlotte Casper, Jan Albert, Thomas Leitner	36
9	Polarisation switching in vertical-cavity surface-emitting lasers: from experimental observations to applications 2001 ·Opto-Electronics Review ·Guy Verschaffelt, Krassimir Panajotov, Jan Albert, Bob Nagler, Michaël Peeters, Jan Danckaert, Irina Veretennicoff, Hugo Thienpont	18
10	Length Variation of Glycoprotein 120 V2 Region in Relation to Biological Phenotypes and Coreceptor Usage of Primary HIV Type 1 Isolates 2001 ·AIDS Research and Human Retroviruses ·Marianne Jansson, (unknown), Gabriella Scarlatti, Åsa Björndal, Shunji Matsuda, Paolo Rossi, Jan Albert, Hans Wigzell	31
11	Evidence of the Existence of a New Circulating Recombinant Form of HIV Type 1 Subtype A/J in Cameroon 2000 ·AIDS Research and Human Retroviruses ·(unknown), Guillermina Laura Dolcini, Philippe Mauclère, Éva Mária Fenyõ, Françoise Barré‐Sinoussi, Jan Albert, Elisabeth Menu	18
12	Assay of Plasma Samples Representing Different HIV-1 Genetic Subtypes: An Evaluation of New Versions of the Amplicor HIV-1 Monitor Assay 1999 ·AIDS Research and Human Retroviruses ·Annette Alaeus, (unknown), Steven A. Herman, Joanne P. Spadoro, June Wang, Jan Albert	24
13	CD8 ⁺ T Cells from HIV Type 1-Seronegative Individuals Suppress Virus Replication in Acutely Infected Cells 1997 ·AIDS Research and Human Retroviruses ·Bård I. Røsok, (unknown), Britt‐Marie Larsson, Jan Albert, Jan E. Brinchmann, Birgitta Åsjö	30
14	Comparison of the Sensitivities of Primary Isolates of HIV Type 2 and HIV Type 1 to Antiviral Drugs and Drug Combinations 1994 ·AIDS Research and Human Retroviruses ·S. W. Cox, (unknown), Jan Albert, Britta Wahrén	29
15	Impaired Parathyroid Hormone Release in Human Immunodeficiency Virus Infection 1994 ·AIDS Research and Human Retroviruses ·Per Hellman, Jan Albert, Magnus Gidlund, Lars Klareskog, Jonas Rastad, Göran Åkerström, Claes Juhlin	22
16	Loss of Synergistic Response to Combinations Containing AZT in AZT-Resistant HIV-1 1992 ·AIDS Research and Human Retroviruses ·S. W. Cox, Jan Albert, Johan Wahlberg, Mathias Uhlén, Britta Wahrén	17
17	Analysis of the V3 Loop in Neutralization-Resistant Human Immunodeficiency Virus Type 1 Variants by Direct Solid-Phase DNA Sequencing 1991 ·AIDS Research and Human Retroviruses ·Johan Wahlberg, Jan Albert, Joakim Lundeberg, (unknown), Kristina Broliden, G Utter, (unknown), Mathias Uhlén	35
18	Vaccine Protection Against HIV-2 Infection in Cynomolgus Monkeys 1991 ·AIDS Research and Human Retroviruses ·Per Putkonen, Rigmor Thorstensson, Lilian Walther–Jallow, Jan Albert, Lennart Åkerblom, (unknown), Göran Wadell, Erling Norrby, Gunnel Biberfeld	57
19	Naturally Occurring HIV-1 Isolates with Differences in Replicative Capacity are Distinguished by In Situ Hybridization of Infected Cells 1990 ·AIDS Research and Human Retroviruses ·Birgitta Åsjö, (unknown), Linda Morfeldt-Månson, (unknown), (unknown), Jan Albert, (unknown), (unknown), (unknown), Peter Biberfeld, Eva Maria Fenyö	27
20	A New Human Retrovirus Isolate of West African Origin (SBL-6669) and Its Relationship to HTLV-IV, LAV-II, and HTLV-IIIB 1987 ·AIDS Research and Human Retroviruses ·Jan Albert, (unknown), Francesca Chiodi, Blenda Böttiger, Éva Mária Fenyõ, Erling Norrby, Gunnel Biberfeld	108

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact